Bumetanide Injection shortage
Resolved 12 presentations · 5 manufacturers · first FDA posting Dec 13, 2017 · last update Sep 30, 2026
Manufacturers: Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc., MSN Laboratories Private Limited, Mullan Pharmaceutical Inc., Sagent Pharmaceuticals
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Bumetanide, Injection, .25 mg/1 mL (NDC 65219-570-04) | Fresenius Kabi USA, LLC | Resolved | — | Available | Posted Jan 31, 2018 Updated Sep 30, 2026 |
| Bumetanide, Injection, .25 mg/1 mL (NDC 65219-572-10) | Fresenius Kabi USA, LLC | Resolved | — | Available | Posted Jan 31, 2018 Updated Sep 30, 2026 |
| Bumetanide, Injection, .25 mg/1 mL (NDC 0641-6007-10) | Hikma Pharmaceuticals USA, Inc. | Resolved | — | Available | Posted Jan 31, 2018 Updated Sep 30, 2026 |
| Bumetanide, Injection, .25 mg/1 mL (NDC 0641-6008-10) | Hikma Pharmaceuticals USA, Inc. | Resolved | — | Available | Posted Jan 31, 2018 Updated Sep 30, 2026 |
| Bumetanide, Injection, 0.25 mg/mL, 4mL (NDC 72205-101-01) | MSN Laboratories Private Limited | Resolved | — | Available | Posted Dec 13, 2017 Updated Sep 30, 2026 |
| Bumetanide, Injection, 0.25 mg/1 mL (NDC 72205-101-07) | MSN Laboratories Private Limited | Resolved | — | Available | Posted Dec 13, 2017 Updated Sep 30, 2026 |
| Bumetanide, Injection, 0.25 mg/mL, 10 mL (NDC 72205-102-01) | MSN Laboratories Private Limited | Resolved | — | Available | Posted Dec 13, 2017 Updated Sep 30, 2026 |
| Bumetanide, Injection, 0.25 mg/1 mL (NDC 72205-102-07) | MSN Laboratories Private Limited | Resolved | — | Available | Posted Dec 13, 2017 Updated Sep 30, 2026 |
| Bumetanide, Injection, 1 mg/4 mL (0.25 mg/mL) (NDC 83301-0080-2) | Mullan Pharmaceutical Inc. | Resolved | — | Available | Posted Dec 13, 2017 Updated Sep 30, 2026 |
| Bumetanide, Injection, 2.5 mg/10 mL (0.25 mg/mL) (NDC 83301-0081-2) | Mullan Pharmaceutical Inc. | Resolved | — | Available | Posted Dec 13, 2017 Updated Sep 30, 2026 |
| Bumetanide, Injection, .25 mg/1 mL (NDC 25021-321-04) | Sagent Pharmaceuticals | Resolved | — | Available | Posted Jan 31, 2018 Updated Sep 30, 2026 |
| Bumetanide, Injection, .25 mg/1 mL (NDC 25021-321-10) | Sagent Pharmaceuticals | Resolved | — | Available | Posted Jan 31, 2018 Updated Sep 30, 2026 |